Tenet Healthcare Corporation THC recently inked a partnership deal with Steward Health Care System, LC to divest its five hospitals and related operations in the Miami-Dade and Southern Broward counties. Per the terms of the deal, the company will get $1.1 billion for this sale. The transaction is expected to close in the third quarter of 2021.
The five Florida hospitals included in the sale are Coral Gables Hospital, Florida Medical Center in Lauderdale Lakes, Hialeah Hospital, North Shore Medical Center in Miami and Palmetto General Hospital in Hialeah.
Per the terms of the deal, Tenet’s Conifer Health Solutions subsidiary will continue to provide revenue cycle management services to these five hospitals post the sale. The hospital company’s ambulatory facilities, run by United Surgical Partners International, in the aforementioned markets are not included in the divestiture.
Notably, closure of this deal will help Steward Health further penetrate in the Florida region. The deal will bring its total hospital count to 44 across the world.
Rationale Behind the Deal
Tenet Healthcare is focused on divesting its non-core and unprofitable business units to repay its debt and maintain financial liquidity. The company exited the first quarter of 2021 with $15 billion of long-term debt, down 3% from the level at 2020 end. The latest move is in line with its strategy of business rejig.
The company’s strategic priorities include completing hospital divestitures and allocating capital to higher return on investments across its capital structure.
The spin-off of its Conifer business into an independent publicly-traded unit is expected to close by the end of 2021. The company is likely to reduce its debt burden by using the proceeds from the above-mentioned transaction.
In April, this presently Zacks Rank #3 (Hold) company completed the sale of its urgent care platform for a valuation of $80 million. The divestment includes the sale of 87 CareSpot and MedPost centers, previously managed by Tenet Healthcare’s United Surgical Partners International (USPI) subsidiary.
These divestitures will help Tenet Healthcare focus on its core operations and aid the stock to continue its rally.
Shares of Tenet Healthcare have soared 212.2% in the past year, outperforming its industry’s increase of 101.2%. This solid upside was primarily driven by the company’s strong fundamentals like alliances, acquisitions and divestitures of its non-core business units. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Image Source: Zacks Investment Research
The price performance looks stellar when compared to other stocks in the same space like HCA Healthcare, Inc. HCA, Universal Health Services, Inc. UHS and MEDNAX, Inc. MD, which too have rallied 106.6%, 57.7% and 75.8%, respectively, in the same time frame.
Time to Invest in Legal Marijuana
If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.
After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%
You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.
Today, Download Marijuana Moneymakers FREE >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Universal Health Services, Inc. (UHS): Free Stock Analysis Report
Tenet Healthcare Corporation (THC): Free Stock Analysis Report
MEDNAX, Inc. (MD): Free Stock Analysis Report
HCA Healthcare, Inc. (HCA): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.